Plasma pentazocine radioimmunoassay.

Area of Science:

• Pharmacology
• Analytical Chemistry

Background:

• Pentazocine is an opioid analgesic with significant clinical use.
• Accurate quantification of pentazocine in biological samples is essential for pharmacokinetic studies.

Purpose of the Study:

• To develop and validate a sensitive and specific radioimmunoassay (RIA) for measuring pentazocine in plasma.
• To apply the developed RIA to determine pentazocine plasma concentrations in beagle hounds.

Main Methods:

• A radioimmunoassay was developed using rabbit antiserum and a second antibody method for separation.
• An 125I-labeled radioligand was employed, requiring sample extraction prior to quantitation.
• The assay demonstrated a detection limit of approximately 200 pg/assay tube (1 ng/ml).

Main Results:

• The RIA successfully measured pentazocine in beagle hound plasma after intravenous administration.
• Plasma pentazocine levels followed a two-compartment body model.
• The mean overall half-life was 100 minutes, with a mean plasma clearance rate of 3.2 liters/hr.

Conclusions:

• A validated radioimmunoassay provides a sensitive and specific method for pentazocine quantification.
• The pharmacokinetic profile of pentazocine in beagle hounds was characterized, informing its disposition in vivo.
• This assay is suitable for clinical and research applications involving pentazocine pharmacokinetics.